Patents by Inventor Patricia Parnet

Patricia Parnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating inflammatory disorders of the lungs
    Patent number: 8034343
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: October 11, 2011
    Assignee: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • METHODS OF TREATING INFLAMMATORY DISORDERS OF THE LUNGS
    Publication number: 20100080804
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Application
    Filed: October 22, 2009
    Publication date: April 1, 2010
    Applicant: IMMUNEX CORPORATION
    Inventors: PATRICIA PARNET, JOHN E. SIMS
  • Methods for determining 2F1-binding compounds
    Patent number: 7625710
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: December 1, 2009
    Assignee: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • ANTIBODIES THAT BIND RECEPTOR PROTEIN DESIGNATED 2F1
    Publication number: 20080213793
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Application
    Filed: June 25, 2007
    Publication date: September 4, 2008
    Applicant: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • Antibodies that bind receptor protein designated 2F1
    Patent number: 7235238
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: June 26, 2007
    Assignee: Amgen Inc.
    Inventors: Patricia Parnet, John E. Sims
  • Methods for treating inflammation with 2F1 antibody
    Patent number: 7001599
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: February 21, 2006
    Assignee: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • Antibodies that bind receptor protein designated 2F1
    Publication number: 20040253682
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Application
    Filed: May 28, 2004
    Publication date: December 16, 2004
    Applicant: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • Antibodies to the receptor protein designated 2F1
    Patent number: 6492496
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation. In addition, antibodies specific to 2F1 polypeptide are provided.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: December 10, 2002
    Assignee: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • Receptor protein designated 2F1
    Publication number: 20020143155
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Application
    Filed: May 28, 2002
    Publication date: October 3, 2002
    Applicant: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • Treatment of inflammation using a 2F1 polypeptide or an antibody thereto
    Patent number: 6451760
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: September 17, 2002
    Assignee: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • Receptor protein designated 2F1
    Patent number: 6090918
    Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Grant
    Filed: July 6, 1998
    Date of Patent: July 18, 2000
    Assignee: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims
  • DNA encoding type-I interleukin-I receptor-like protein designated 2F1
    Patent number: 5776731
    Abstract: 2F1 polypeptides members of the IL-1 receptor family are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: July 7, 1998
    Assignee: Immunex Corporation
    Inventors: Patricia Parnet, John E. Sims